O ũndũ mũndũ ũnyusaa sikala kwa ĩvinda ĩasa na mavinda maingĩ, now'o ũthĩawa ũtonya kũkwatwa nĩ mowau asu.
2. Kũnyw'a sikala: Mũndũ ũla ũnyusaa sikala no akwatwe nĩ kanza ya mavũi.
3. Ĩthimo ya nzeve yĩtawa radon: Ĩthimo ya nzeve yĩtawa radon yĩthĩawa mĩsyĩnĩ na no ĩtume mũndũ akwatwa nĩ kanza ya mavũi.
4. Asbestos na syĩndũ ingĩ itonya kũtuma mũndũ awaa nĩ kanza: Syĩndũ ta asbestos, arsenic, chromium, nickel, na syĩndũ ingĩ nitonya kũtuma mũndũ awaa nĩ kanza ya mavũi.
5. Kũvukya nzeve: Mũndũ eethĩwa na nzeve nthũku kwa ĩvinda ĩasa nũtonya kũkwata kanza ya mavũi.
6. Andũ amwe ma mũsyĩ nĩmatonya kwĩthĩwa makwatĩtwe nĩ kanza ya mavũi.
7. Ũkũũ: Mũndũ akũa nũtonya kũkwatwa nĩ kanza ya mavũi, na mũno mũno ethĩwa e na myaka mbee wa 65.
8. Mũndũũme kana mũndũ mũka: Aũme nĩmo makothaa kũkwatwa nĩ kanza ya mavũi kwĩ aka.
9. Mũndũ eethĩwa na ũwau wa mavũi: Andũ ala tene maĩ na ũwau wa mavũi ta ũwau mũthũku wa kũsiĩĩa kũkua kwa nzeve (COPD) kana ũwau wa kĩthũi (tuberculosis) nĩmatonya kwĩthĩwa na ũwau ũsu.
10. Kũteea mũndũ na kyeni kĩthũinĩ: Andũ ala makwatĩtwe nĩ mowau angĩ ma kanza na makathi kũteew'a kyeni kĩthũinĩ nĩmatonya kũkwatwa nĩ kanza ya mavũi.
Nĩ ũndũ wa vata kũmanya kana ti andũ onthe me na maũndũ matonya kũtuma makwatwa nĩ kanza ya mavũi, na ti andũ onthe methĩawa na maũndũ matonya kũtuma makwatwa nĩ kanza ĩsu.
Couraud S, Grolleau E: [How to implement lung cancer screening ?] Rev Prat. 2020, 70 (8): 864-867.
Casutt A, Lovis A, Selby K, Noirez L, Peters S, Beigelman-Aubry C, Krueger T, Soccal PM, Von Garnier C: [Lung cancer screening in Switzerland : Who ? How ? When ?] Rev Med Suisse. 2020, 16 (715): 2224-2226.
Peres J: Lung cancer screening gets risk-specific. J Natl Cancer Inst. 2013, 105 (1): 1-2.
McNeil C: Combined therapy for lung cancer gets a boost. J Natl Cancer Inst. 1996, 88 (17): 1182-4.
Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Grimaud E, Labbe M, Contesso G, Le M: Radiation dose, chemotherapy and risk of lung cancer after breast cancer treatment. Breast Cancer Res Treat. 2002, 75 (1): 15-24.
Ali Mohammed Hammamy R, Farooqui K, Ghadban W: Sclerotic Bone Metastasis in Pulmonary Adenocarcinoma. Case Rep Med. 2018, 2018 (): 1903757.
Wu J, Ma L, Wang J, Qiao Y: [Mechanism of Ferroptosis and Its Research Progress in Lung Cancer]. Zhongguo Fei Ai Za Zhi. 2020, 23 (9): 811-817.
Cancer Screening Gets Thumbs-up From Readers. Manag Care. 2017, 26 (5): 30-31.
['Ũtao:']
["Kĩsese kĩĩ kĩseũvĩtw'e kwondũ wa kũmanyĩsya na kũtetheesya andũ, ĩndĩ ti kũnengane motao ma ũiiti kana ũtethyo ũngĩ."]
['Ũvoo ũla wĩ vo ndwaĩle kũtũmĩwa kũĩkĩĩthya kana mũndũ e na ũwau mũna, na ala mekwenda ũtao wa ũiiti maĩle kũneena na ndakĩtalĩ.']
["Kwa ngelekany'o, ĩla mũndũ wakũlya ĩkũlyo yĩ na namba, no amanye kana mũndũ ũsu e na ũwau mũna."]
['Kĩla ĩvinda neena na ndakĩtalĩ waku kana mũndũ ũngĩ ũsomeete maũndũ ma ũiiti. Ndũkaatate kũlea kana kũkua ĩvinda ũimũkũlya ũtao aĩ nũndũ wa maũndũ amwe wasoma Kĩsesenĩ kĩĩ. Ethĩwa wĩona ta wĩ na thĩna wa mĩtũkĩ, neena na namba ya 911 kana ũthi sivitalĩ ya mĩtũkĩ ĩla yĩ vakuvĩ.']
['Ũtao:']
['The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) nĩyaĩtye kana ala me na ũthasyo wa kumĩthya syĩndũ ila syĩ Indanetinĩ nĩmaĩle kũtata ũndũ matonya nĩ kana maĩkĩĩthye kana syĩndũ ila mekumĩthya nĩsyavĩnga mĩao ya nthĩ ya Amelika.']
['Ethĩwa wĩ na mũĩkĩĩo kana ũvoo ũla wĩ kĩsesenĩ kitũ kana nthĩnĩ wa syĩndũ ila tumasya nũvĩtĩsye mĩao yaku, no ũtũtũmĩe valũa ũũtwĩĩte kana no ũtũsiĩĩe tũikamĩsome.']
["Mĩao ya DMCA yaĩtye kana no nginya ũvoo ũla ũũtũmĩa kũtũtavya kana ve kĩndũ kĩna kĩnavĩnga mĩao ya kumĩthya syĩndũ wĩthĩwe na ũvoo ũũ: (1) ũvoo ĩũlũ wa syĩndũ ila iwetetwe kana nĩsyo ivĩngĩĩsiwe nĩ mĩao ĩsu; (2) ũvoo ĩũlũ wa syĩndũ ila iwetetwe kana nĩsyo ivĩngĩĩsiwe nĩ mĩao ĩsu na ũvoo ũtonya kũtũtetheesya kũmanya vala syĩndũ isu syĩ; (3) ũndũ ũtonya kũtũtavya ũndũ ũtonya kũtũtavya ũndũ ũtonya kũũkũlya, ta vala wĩkalaa, namba yaku ya simũ, na valũa waku wa simũ; (4) ũĩkĩĩthyo ũkwonany'a kana wĩ na mũĩkĩĩo kana syĩndũ ila iwetetwe vau iyĩtĩkĩlĩtw'e nĩ ũla wĩ na ũthasyo wa kũseũvya syĩndũ, kana nĩ mũũngamĩi wasyo, kana nĩ mĩao ĩngĩ."]
["(5) ũĩkĩĩthyo kuma kwaku, ũla ũandĩkĩte ũikĩa ũkũsĩ ũte wa w'o, kana ũvoo ũla wĩ nthĩnĩ wa livoti nĩ wa w'o na kana wĩ na ũkũmũ wa kũũngamĩa maũndũ ala mawetwa nĩ ũla ũkũũmĩw'a;"]
['Na (6) saii ya mwene syĩndũ kana mũndũ ũla ũnengetwe ũkũmũ wa kwĩka maũndũ kwondũ wake.']
Lung cancer can affect anyone, but certain factors can increase the risk of developing the disease.
These include:
1. Smoking: Smoking is the leading cause of lung cancer.
The longer a person smokes and the more cigarettes they smoke, the greater their risk.
2. Secondhand smoke: Exposure to secondhand smoke can also increase the risk of lung cancer.
3. Radon gas: Exposure to radon gas, a naturally occurring radioactive gas that can accumulate in homes, can increase the risk of lung cancer.
4. Asbestos and other carcinogens: Exposure to asbestos, arsenic, chromium, nickel, and other substances can increase the risk of lung cancer.
5. Air pollution: Long-term exposure to air pollution can increase the risk of lung cancer.
6. Family history: A family history of lung cancer may increase a person's risk.
7. Age: The risk of lung cancer increases with age, with most cases occurring in people over the age of 65.
8. Gender: Men are more likely to develop lung cancer than women.
9. Personal history of lung disease: People with a history of lung diseases such as chronic obstructive pulmonary disease (COPD) or tuberculosis may have an increased risk of lung cancer.
10. Radiation therapy to the chest: People who have had radiation therapy to the chest for other cancers have an increased risk of lung cancer.
It is important to note that not everyone with risk factors will develop lung cancer, and some people who do develop lung cancer may not have any known risk factors.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
